Elsevier

Clinical Immunology

Volume 105, Issue 2, November 2002, Pages 141-154
Clinical Immunology

Regular Article
Evaluation of Antigen-Based Heteropolymer for Treatment of Systemic Lupus Erythematosus in a Nonhuman Primate Model

https://doi.org/10.1006/clim.2002.5274Get rights and content

Abstract

Autoantibodies that react with double-stranded DNA (dsDNA) are a hallmark for diagnosis of systemic lupus erythematosus (SLE) and are also considered the pathogenic subset that is most associated with lupus nephritis. As an agent to remove the pathogenic dsDNA antibodies from the circulation of SLE patients, we are developing an antigen-based heteropolymer (AHP). The AHP consists of a monoclonal antibody to the complement receptor (CR1) cross-linked to salmon testis dsDNA to effect clearance of anti-DNA antibodies by binding them to erythrocyte CR1. Utilizing a cynomolgus monkey model for SLE in which we infused plasma from SLE patients containing a high titer of high-avidity anti-dsDNA antibody, we have evaluated the safety and efficacy of AHP infusion. The results demonstrate that AHP rapidly (within 2 min of infusion) binds to monkey erythrocytes without causing any toxicological effects. We also demonstrate that human Ig (G+M) antibodies are rapidly bound to the AHP–erythrocyte complex. These events are mirrored in their kinetics by a substantial drop in the level of high-avidity dsDNA antibody in the plasma.

References (44)

  • R.P. Taylor et al.

    Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 Mabs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model

    Clin. Immunol. Immunother.

    (1997)
  • M.L. Reinagel et al.

    The primate erythrocyte complement receptor (CR1) as a privileged site: Binding immunoglobulin to erythrocyte CR1 does not target erythrocytes for phagocytosis

    Blood

    (1997)
  • M.N. Hylkema et al.

    Histone-containing immune complexes are to a large extent responsible for anti-dsDNA reactivity in the Farr assay of active SLE patients

    J. Autoimmun.

    (2000)
  • V.J. Gauthier et al.

    Immune complexes in systemic lupus erythematosus

  • E.M. Tan et al.

    Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic erythematosus

    J. Clin. Invest.

    (1966)
  • J.B. Winfield et al.

    Avidity of anti-dsDNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus

    J. Clin. Invest.

    (1977)
  • B. Hecht et al.

    Prognostic indices in lupus nephritis

    Medicine

    (1976)
  • H. Bootsma et al.

    The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus: A prospective long term observation

    Ann. Rheum. Dis.

    (1997)
  • A.J.G. Swaak et al.

    Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus

    Arthritis Rheum.

    (1979)
  • A.J.G. Swaak et al.

    Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus

    Ann. Rheum. Dis.

    (1986)
  • W. Emlen et al.

    Antibodies to DNA: A perspective

    Arthritis Rheum.

    (1986)
  • Cited by (0)

    1

    To whom correspondence should be addressed. Fax: (973) 808-0322. E-mail: [email protected].

    View full text